Acesso livre
Acesso livre

Clínica Médica

Podcast | Cura da hepatite C.

27 Abr, 2022 | 16:12h

#329 Curing Hepatitis C – The Curbsiders

Gota no departamento de emergência: dicas e armadilhas.

27 Abr, 2022 | 16:03h

Gout in the ED: Pearls and Pitfalls – emDocs

Diretriz NICE | Medicamentos associados a dependência ou recidiva de sintomas: prescrição segura e retirada de tratamento para adultos.

27 Abr, 2022 | 15:51h

Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults – National Institute for Health and Care Excellence

Estudo de coorte | Associação da eleição presidencial norte-americana em 2020 com internações por condições cardiovasculares agudas.

27 Abr, 2022 | 15:47h

Association of the 2020 US Presidential Election With Hospitalizations for Acute Cardiovascular Conditions – JAMA Network Open

Conteúdos relacionados:

Psychological Stress and Heart Disease: Fact or Folklore? – The American Journal of Medicine

Sudden Cardiac Death Triggered by an Earthquake – New England Journal of Medicine

Cardiovascular Events during World Cup Soccer – New England Journal of Medicine

 

Comentário do autor no Twitter (fio – clique para saber mais)

 

Estudo observacional multinacional | Achados ecocardiográficos em pacientes com COVID-19 admitidos em UTI.

27 Abr, 2022 | 15:43h

Echocardiography findings in COVID-19 patients admitted to intensive care units: a multi-national observational study (the ECHO-COVID study) – Intensive Care Medicine

 

Comentário no Twitter

 

Estudo de coorte | Associação de pressão arterial cumulativa com declínio cognitivo, demência e mortalidade.

27 Abr, 2022 | 15:29h

Association of Cumulative Blood Pressure With Cognitive Decline, Dementia, and Mortality – Journal of the American College of Cardiology

Comentário: Association of Blood Pressure With Cognitive Decline, Dementia, and Mortality – American College of Cardiology

Ponto/Contraponto | Apneia obstrutiva do sono assintomática deveria ser tratada em pacientes com doença cardiovascular importante?

27 Abr, 2022 | 15:25h

PONTO: Should Asymptomatic OSA Be Treated in Patients With Significant Cardiovascular Disease? Yes – CHEST

CONTRAPONTO: Should Asymptomatic OSA Be Treated in Patients With Significant Cardiovascular Disease? No – CHEST

Medicamentos anticolinérgicos e demência: deveríamos nos preocupar?

27 Abr, 2022 | 15:21h

Commonly-prescribed drugs and dementia: should we be worried? – Evidently Cochrane

Revisão original: Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome – Cochrane Library

Editorial: Anticholinergic drugs and dementia: time for transparency in the face of uncertainty – Cochrane Library

Conteúdos relacionados:

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models – Drugs & Aging

Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study – JAMA Internal Medicine

How well do you know your anticholinergic (antimuscarinic) drugs? – Therapeutics Initiative

Anticholinergic drugs and risk of dementia: case-control study – The BMJ

 

Comentário no Twitter

 

Estudo de coorte | Progressão do diabetes entre idosos com pré-diabetes definida por hemoglobina A1c foi de cerca de 5% após um seguimento médio de 2,3 anos.

27 Abr, 2022 | 15:16h

Progression to Diabetes Among Older Adults With Hemoglobin A1c–Defined Prediabetes in the US – JAMA Network Open

Comentário: How Often Does Prediabetes in Seniors Escalate to Full-Blown Disease? – MedPage Today (link para o resumo – $ para o texto completo)

New Research Explores Diabetes Progression Rate in Older Adults with Prediabetes – HCP Livre

Estudo relacionado: Risk of Progression to Diabetes Among Older Adults With Prediabetes – JAMA Internal Medicine e Comentário: “Prediabetes” Diagnosis Less Useful in Older Patients – Johns Hopkins Bloomberg School of Public Health

 

Comentário no Twitter

 

OMS recomenda o nirmatrelvir-ritonavir para o tratamento da COVID-19 e pede para uma maior distribuição geográfica.

25 Abr, 2022 | 12:47h

WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator – World Health Organization

Ver também:

A living WHO guideline on drugs for covid-19 – The BMJ

Therapeutics and COVID-19: living guideline – World Health Organization

Conteúdos relacionados:

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 – New England Journal of Medicine

Prescribing Nirmatrelvir–Ritonavir: How to Recognize and Manage Drug–Drug Interactions – Annals of Internal Medicine

The COVID-19 Treatment Guidelines Panel’s Statement on Potential Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Concomitant Medications – NIH COVID-19 Treatment Guidelines Panel

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.